NEW ORLEANS — Looking at 185 countries, a projection presented at the ASH Annual Meeting and Exhibition suggests the global burden of non-Hodgkin lymphoma will increase by 778,000 cases by 2040.“We saw the growing incident trends in non-Hodgkin lymphoma particularly among the elderly population and the large increase in the incidence may indicate the growing prevalence of risk factors
/PRNewswire/ Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.
JINAN, China, Dec. 20, 2022 /PRNewswire/ According to information released on December 13 by the People's Government of Huaiyin District, Huaiyin will expend all necessary effort on building